Bharath Balu spent many years working in the Tropical Disease Research Program in the Center for Infectious Disease and Biodefense Research in SRI Biosciences, looking to find the break through that would lead to a new drug treatment for malaria. Bharath Balu looked past the effects of malaria, into the molecular and cellular makeup of the malaria parasite. Bharath Balu has spent 15 years studying the malaria parasite, at the Tropical Disease Research Program at SRI Biosciences, the Department of Global Health at the University of South Florida, and at the University of Notre Dame.